PPAR agonists
US9938234B2 · kind B2 · utility
12Cited by
2References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 2, 2015 |
| Grant date | Apr 10, 2018 |
| Priority date | — |
| Expiry date | Oct 2, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds and compositions useful in increasing PPARδ activity. The compounds and compositions provided herein are useful for the treatment of PPARδ related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.